Publication Date:
2012-12-07
Description:
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation Cell Death and Disease 3, e441 (December 2012). doi:10.1038/cddis.2012.181 Authors: E Fokas, R Prevo, J R Pollard, P M Reaper, P A Charlton, B Cornelissen, K A Vallis, E M Hammond, M M Olcina, W Gillies McKenna, R J Muschel & T B Brunner
Keywords:
ATRnovel inhibitorradiosensitiserpancreatic cancertumor selectivity
Electronic ISSN:
2041-4889
Topics:
Biology
,
Medicine
Permalink